By Devika Patel
Knoxville, Tenn., Aug. 9 - Raptor Pharmaceutical Corp. said it has arranged a $15.06 million private placement of units. JMP Securities LLC is the agent.
The company will sell 4,897,614 units at $3.075 apiece. Each unit consists of one common share and one warrant, with each five-year warrant exercisable at $3.075.
The strike price and the price per share reflect a 3.89% premium to the closing share price of $2.96 on Aug. 6.
Raptor is a Novato, Calif., biotechnology company that bioengineers novel drugs and drug-targeting platforms derived from the human receptor-associated protein and related proteins.
| Issuer: | Raptor Pharmaceutical Corp.
|
| Issue: | Units of one common share and one warrant
|
| Amount: | $15,060,163
|
| Units: | 4,897,614
|
| Price: | $3.075
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $3.075
|
| Agent: | JMP Securities LLC
|
| Pricing date: | Aug. 9
|
| Stock symbol: | Nasdaq: RPTP
|
| Stock price: | $2.97 at close Aug. 9
|
| Market capitalization: | $74.1 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
